Sociogeographic determinants of rapid opioid reduction or discontinuation among patients on high-dose long-term opioid therapy in North Carolina, 2006–2018 - Scorecard - MDSpire
Advertisement
Sociogeographic determinants of rapid opioid reduction or discontinuation among patients on high-dose long-term opioid therapy in North Carolina, 2006–2018
Clinical Scorecard: Geographic and Social Factors Influencing Swift Opioid Reduction or Cessation in High-Dose Long-Term Opioid Therapy Patients in North Carolina, 2006–2018
At a Glance
Category
Detail
Condition
High-dose long-term opioid therapy (HD-LTOT) and rapid opioid reduction or discontinuation
Key Mechanisms
Residential segregation, health care access, individual mental health diagnoses, and demographic factors influence rapid opioid tapering risks
Target Population
Adults aged 18–64 on HD-LTOT (≥90 MME for ≥81 of 90 consecutive days) in North Carolina
Care Setting
Outpatient opioid prescribing and management within private insurance healthcare systems
Key Highlights
Rapid opioid reduction or discontinuation in HD-LTOT patients is linked to increased risks of heroin use, overdose, opioid use disorder, and mental health crises.
Patients living in racially and economically marginalized neighborhoods, especially females and those with PTSD, have higher risks of rapid opioid tapering.
Healthcare providers should address biases and mental health stigma to deliver equitable, unbiased care during opioid tapering.
Guideline-Based Recommendations
Diagnosis
Identify patients on HD-LTOT using opioid dosage thresholds (≥90 MME for ≥81 of 90 days).
Screen for mental health conditions including PTSD, depression, anxiety, and substance use disorders.
Assess neighborhood-level factors such as residential segregation and healthcare access as part of risk evaluation.
Management
Avoid rapid opioid reduction or discontinuation, especially in high-dose patients, to minimize withdrawal and adverse outcomes.
Prioritize training to reduce provider biases and stigma, particularly for patients from underserved communities and those with mental health diagnoses.
Monitoring & Follow-up
Monitor patients closely during opioid tapering for signs of withdrawal, mental health crises, and risk of illicit opioid use.
Consider individual and neighborhood-level risk factors when planning and adjusting opioid tapering strategies.
Risks
Rapid opioid tapering increases risk of heroin use, opioid overdose (fatal and nonfatal), opioid use disorder, and mental health crises.
Patients in racially and economically segregated neighborhoods may face disproportionate risks due to systemic inequities.
Female patients and those with PTSD are at elevated risk for rapid opioid reduction-related adverse outcomes.
Patient & Prescribing Data
13,375 patients on HD-LTOT in North Carolina with private insurance, aged 18–64
Nearly half (48.6%) experienced rapid opioid reduction or discontinuation within 1 year; risks were higher among females and patients with PTSD in marginalized neighborhoods.
Clinical Best Practices
Incorporate assessment of social determinants such as residential segregation and healthcare access into opioid management plans.
Engage in culturally competent, unbiased care with attention to intersectionality of race, socioeconomic status, and mental health.
Implement gradual opioid tapering protocols aligned with CDC guidelines to reduce adverse outcomes.
Provide additional support and monitoring for patients with mental health diagnoses, especially PTSD.
Educate healthcare providers on the impact of systemic inequities and mental health stigma in opioid prescribing and tapering.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
